Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (23)

« Back to Publications

Trends in use of Attention-Deficit Hyperactivity Disorder medications among children and adults in five European countries, 2010 to 2023: a population-based observational study.

Li X. et al, (2026), Lancet Reg Health Eur, 61

CohortSymmetry: An R package to perform sequence symmetry analysis using the OMOP common data model

Chen X. et al, (2025)

“Double Machine Learning for Causal Inference in High-Dimensional Electronic Health Records”

Du M. et al, (2025)

The post-authorisation safety of COVID-19 vaccines: real-world evidence

Li X., (2024)

IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model.

Raventós B. et al, (2024), Pharmacoepidemiol Drug Saf, 33

The role of COVID-19 vaccines in preventing post COVID-19 thromboembolic and cardiovascular complications: a multinational cohort study

Mercadé-Besora N. et al, (2023)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom.

Burn E. et al, (2022), Nat Commun, 13

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.

Burn E. et al, (2022), Nat Commun, 13

Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.

Li X. et al, (2022), BMJ, 379

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.

Burn E. et al, (2022), Pharmacoepidemiol Drug Saf, 31, 495 - 510

ssociation between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.

Li X. et al, (2022), BMJ, 376

The impact of prioritisation and dosing intervals on the effects of COVID-19 vaccination in Europe: an agent-based cohort model.

Català M. et al, (2021), Sci Rep, 11

ssociations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.

Cabezas C. et al, (2021), BMJ, 374

Bias, precision and timeliness of historical (background) rate comparison methods for vaccine safety monitoring: an empirical multi-database analysis

Li X. et al, (2021)

Empirical evaluation of the sensitivity of background incidence rate characterization for adverse events across an international observational data network

Ostropolets A. et al, (2021)

Load More